What Does MACD Oscillator Analysis predict about Repros Therapeutics Inc. (NASDAQ:RPRX)?

60

Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Repros Therapeutics Inc. (NASDAQ:RPRX) for the period of 9-Day stands at 53.22% while the stochastic %D for the same period stands at 59.36%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Repros Therapeutics Inc. (NASDAQ:RPRX) signals “Buy” while other important signals like the 20-Day Moving Average Vs. Price signals “Buy”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for Repros Therapeutics Inc. (NASDAQ:RPRX) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently Repros Therapeutics Inc. (NASDAQ:RPRX)’s 20-Day Bollinger Band indicates “Hold”.

About Company

Zonagen Inc. is a biopharmaceutical company engaged in the development of products for the human reproductive system, including sexual dysfunction, vaccine adjuvants, products for fertility and female health as well as urological applications, specifically prostate cancer.  Zonagen’s products to treat sexual dysfunction all incorporate phentolaminemesylate, an alpha-adrenergic blocker, as the active agent.  Zonagen’s lead product, VASOMAX(R), is a rapidly disintegrating oral formulation of phentolamine for the treatment of male erectile dysfunction.

Previous Day Activity Analysis

On the last trading day, Repros Therapeutics Inc. (NASDAQ:RPRX) opened the session at $0.65 and after going down -10.14% closed at $0.58. The stock lost -0.07 points in the last trade.

Repros Therapeutics Inc. (NASDAQ:RPRX)’s stock fluctuated in the range of $0.550 and $0.650 during the previous active session. Repros Therapeutics Inc. (NASDAQ:RPRX) traded with the volume of 1.19 Million with average volume of 1.11 Million. The stock has HIGH volatility on the last trading session.

Currently the Beta for the company remains at 0.43 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.09 and 64.49 respectively.

Currently the Insider Ownership of the shares of Repros Therapeutics Inc. (NASDAQ:RPRX) is at 0.2% and the shares outstanding are 41.9 Million.

Important Ratio Analysis

Some important ratios to consider here for Repros Therapeutics Inc. (NASDAQ:RPRX) are discussed below:

Dividend yield of Repros Therapeutics Inc. (NASDAQ:RPRX) stands at 0% whereas Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The PEG ratio (Price to Earning to Growth) emits the value of 0. The Price to Sale P/S and Price to Book P/B shows the value of 0 and 0 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 6.39 and 0 correspondingly.

The Quick Ratio of Repros Therapeutics Inc. (NASDAQ:RPRX) stands at 1.8 while the Current Ratio depicts the value of 1.8.

Return on Assets ROA of Repros Therapeutics Inc. (NASDAQ:RPRX) is at -212.1% whereas, Return on Equity ROE and Return of Investment ROI of Repros Therapeutics Inc. (NASDAQ:RPRX) stand at -412.4% and 0% respectively.

Stock Performance Analysis

The stock performance of Repros Therapeutics Inc. (NASDAQ:RPRX) on the basis of 5 day trade show the jump of 9.36% whereas, the monthly performance of the stock shows increase of 75.64%.

The quarterly performance of the stock remained in green zone with the value of 50.55% while six month performance of the shares of Repros Therapeutics Inc. (NASDAQ:RPRX) remained bearish with the count of -51.7%.

The yearly and YTD performance of Repros Therapeutics Inc. (NASDAQ:RPRX) remained down at -71.02% and -56.09% respectively.